Notes
PCSK9 = proprotein convertase subtillisin/kexin type 9
Reference
Lareb (Netherlands Pharmacovigilance Centre). Reports of muscle complaints with the new cholesterol lowering drugs alirocumab and evolocumab. Internet Document : 12 Sep 2018. Available from: URL: https://www.lareb.nl/en/news/reports-of-muscle-complaints-with-the-new-cholesterol-lowering-drugs-alirocumab-and-evolocumab/
Rights and permissions
About this article
Cite this article
Muscle-related complaints with alirocumab and evolocumab. Reactions Weekly 1721, 2 (2018). https://doi.org/10.1007/s40278-018-52039-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-52039-3